These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 16416222

  • 1. Lafutidine, a newly developed antiulcer drug, elevates postprandial intragastric pH and increases plasma calcitonin gene-related peptide and somatostatin concentrations in humans: comparisons with famotidine.
    Shimatani T, Inoue M, Kuroiwa T, Xu J, Nakamura M, Tazuma S, Ikawa K, Morikawa N.
    Dig Dis Sci; 2006 Jan; 51(1):114-20. PubMed ID: 16416222
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Pharmacokinetic and pharmacodynamic properties of lafutidine after postprandial oral administration in healthy subjects: comparison with famotidine.
    Ikawa K, Shimatani T, Hayato S, Morikawa N, Tazuma S.
    Biol Pharm Bull; 2007 May; 30(5):1003-6. PubMed ID: 17473452
    [Abstract] [Full Text] [Related]

  • 4. Lafutidine, a novel histamine H2-receptor antagonist, increases serum calcitonin gene-related peptide in rats after water immersion-restraint stress.
    Sato H, Kawashima K, Yuki M, Kazumori H, Rumi MA, Ortega-Cava CF, Ishihara S, Kinoshita Y.
    J Lab Clin Med; 2003 Feb; 141(2):102-5. PubMed ID: 12577045
    [Abstract] [Full Text] [Related]

  • 5. Effect of Helicobacter pylori status on intragastric pH during administration of lafutidine or famotidine.
    Koike T, Ohara S, Sehine H, Kawamura M, Abe Y, Inomata Y, Iijima K, Imatani A, Shimosegawa T.
    Hepatogastroenterology; 2007 Jun; 54(76):1280-4. PubMed ID: 17629089
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Afferent signalling from the acid-challenged rat stomach is inhibited and gastric acid elimination is enhanced by lafutidine.
    Edelsbrunner ME, Nakano M, Holzer P.
    BMC Gastroenterol; 2009 Jun 02; 9():40. PubMed ID: 19490646
    [Abstract] [Full Text] [Related]

  • 10. Early effects of lafutidine or rabeprazole on intragastric acidity: which drug is more suitable for on-demand use?
    Inamori M, Togawa J, Iwasaki T, Ozawa Y, Kikuchi T, Muramatsu K, Chiguchi G, Matsumoto S, Kawamura H, Abe Y, Kirikoshi H, Kobayashi N, Shimamura T, Kubota K, Sakaguchi T, Saito S, Ueno N, Nakajima A.
    J Gastroenterol; 2005 May 02; 40(5):453-8. PubMed ID: 15942709
    [Abstract] [Full Text] [Related]

  • 11. Early effects of oral administration of lafutidine with mosapride compared with lafutidine alone on intragastric pH values.
    Iida H, Inamori M, Nozaki Y, Endo H, Hosono K, Akiyama T, Sakamoto Y, Takahashi H, Koide T, Tokoro C, Abe Y, Nakajima A.
    BMC Gastroenterol; 2009 Jul 09; 9():52. PubMed ID: 19589146
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Stronger inhibition of gastric acid secretion by lafutidine, a novel H2 receptor antagonist, than by the proton pump inhibitor lansoprazole.
    Yamagishi H, Koike T, Ohara S, Horii T, Kikuchi R, Kobayashi S, Abe Y, Iijima K, Imatani A, Suzuki K, Hishinuma T, Goto J, Shimosegawa T.
    World J Gastroenterol; 2008 Apr 21; 14(15):2406-10. PubMed ID: 18416470
    [Abstract] [Full Text] [Related]

  • 16. Protective effect of lafutidine, a histamine H2 receptor antagonist, against loxoprofen-induced small intestinal lesions in rats.
    Amagase K, Ochi A, Sugihara T, Kato S, Takeuchi K.
    J Gastroenterol Hepatol; 2010 May 21; 25 Suppl 1():S111-8. PubMed ID: 20586851
    [Abstract] [Full Text] [Related]

  • 17. Effect of lafutidine, a histamine H2-receptor antagonist, on gastric mucosal blood flow and duodenal HCO3- secretion in rats: relation to capsaicin-sensitive afferent neurons.
    Mimaki H, Kagawa S, Aoi M, Kato S, Satoshi T, Kohama K, Takeuchi K.
    Dig Dis Sci; 2002 Dec 21; 47(12):2696-703. PubMed ID: 12498288
    [Abstract] [Full Text] [Related]

  • 18. [Pharmacological and therapeutic properties of lafutidine (stogar and protecadin), a novel histamine H2 receptor antagonist with gastroprotective activity].
    Tanaka M, Banba M, Joko A, Moriyama Y.
    Nihon Yakurigaku Zasshi; 2001 Jun 21; 117(6):377-86. PubMed ID: 11436515
    [Abstract] [Full Text] [Related]

  • 19. Sensitizing effects of lafutidine on CGRP-containing afferent nerves in the rat stomach.
    Nishihara K, Nozawa Y, Nakano M, Ajioka H, Matsuura N.
    Br J Pharmacol; 2002 Mar 21; 135(6):1487-94. PubMed ID: 11906962
    [Abstract] [Full Text] [Related]

  • 20. Lafutidine facilitates calcitonin gene-related peptide (CGRP) nerve-mediated vasodilation via vanilloid-1 receptors in rat mesenteric resistance arteries.
    Sugiyama T, Hatanaka Y, Iwatani Y, Jin X, Kawasaki H.
    J Pharmacol Sci; 2008 Mar 21; 106(3):505-11. PubMed ID: 18344609
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.